| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.0036 | 1 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | 0.00089 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00051 | 1 |